Oncologic Imaging with Whole-Body MRI & PET/MRI
Sunrise Course
ORGANIZERS: Nandita deSouza, Katja Pinker-Domenig
Tuesday, 06 June 2023
713A/B
07:00 -
08:00
Moderators: Nandita deSouza & Jonathan Thiessen
Skill Level: Intermediate to Advanced
Session Number: S-Tu-03
CME Credit
Session Number: S-Tu-03
Overview
This course will provide a comprehensive overview of technique, imaging protocols, available tracers, and clinical applications of PET/MRI. The benefits of hybrid imaging over MRI alone in different clinical scenarios will be discussed.
Target Audience
Basic to Advanced
Educational Objectives
As a result of attending this course, participants should be able to:
- Explain the principles of whole-body imaging with MRI and PET/MRI with different sequences and tracers;
- Identify the clinical applications of whole body MRI and PET/MRI in oncology; and
- Recognize the challenges of whole-body multimodality imaging in clinical practice.
07:00 | | Whole-Body MRI: A Technique Primer Jessica Winfield Keywords: Image acquisition: Whole body, Cross-organ: Cancer, Body: Body This presentation will discuss whole-body MRI (WB-MRI) in oncology, including diffusion-weighted MRI and Dixon imaging. We will discuss recommended WB-MRI protocols, and optimisation of imaging protocols on modern, clinical scanners. Finally, we will discuss some of the artefacts and pitfalls encountered in WB-MRI and techniques for solving common problems. |
07:20 | | PET/MRI as a MR scanner with PET: A Guide to Sequences and Tracers for Comprehensive Whole-body Imaging in Oncology Satoru Takahashi, Munenobu Nogami, Takamichi Murakami Keywords: Physics & Engineering: PET/MR, Body: Body, Image acquisition: Whole Body PET/MRI is a hybrid imaging modality that combines the benefits of PET and MRI. Compared to PET/CT, PET/MRI offers improved soft tissue contrast and avoids ionizing radiation. However, concerns such as long examination times and the challenge of lung imaging remain. To optimize PET/MRI protocols for whole-body imaging in oncology, necessary and sufficient sequences including T1-weighted, T2-weighted, and diffusion-weighted imaging will be discussed. Common tracers for whole-body imaging, such as FDG and PSMA, will be demonstrated with possible clinical scenario. PET/MRI can provide functional and metabolic information in a single study, making it a valuable tool for oncologic imaging. |
07:40 | | Whole-Body PET/MRI: Clinical Applications Jonathan McConathy |